Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/25609
Title: PREVALENCE OF BRONCHIECTASIS IN COPD PATIENTS
Authors: Buklioska Ilievska, Daniela 
Mickovski, Ivana
Neshovska, Radmila
Buklioska, Adriana
Trajkova, Vesna
Minov, Jordan 
Stoleski, Sasho 
Mijakoski, Dragan 
Keywords: COPD
Bronchiectasis
Issue Date: Jan-2023
Source: Buklioska Ilievska D, Mickovski I, Neshovska R, Buklioska A, Trajkova V, Minov J, Stoleski S, Mijakoski D. Prevalence of Bronchiectasis in COPD Patients. 10th Lung Health Workshop, 19-21.01.2023 Niece, France. Abstract book page 20.
Conference: 10TH INTERNATIONAL WORKSHOP ON LUNG HEALTH
Abstract: Introduction - There is increasing recognition that radiological bronchiectasis is present in many patients with COPD. Computed tomography scan images have been used to identify different radiological COPD phenotypes based on the presence and severity of emphysema, bronchial wall thickening, and bronchiectasis. Bronchiectasis is defined as an abnormal dilation of the bronchi, usually as a result of chronic airway inflammation and/or infection. The prevalence of bronchiectasis in patients with COPD is high, especially in advanced stages, estimated prevalence varies from 4% to 50%. Methods - COPD patients underwent chest CT as part of their clinical assessment. Patients were included if COPD was diagnosed based on spirometry and clinical assessment and excluded if there was clinical bronchiectasis. Scoring was by a simplified system based on Smith (Thorax, 1996) and returned a score of 0 (no bronchiectasis), 1 (0–50% of bronchi involved), or 2 (50–100% of bronchi involved) for each lobe, with a total score of 12 including the lingula; emphysema, interstitial lung disease (ILD), or other pathology was noted. A total of 220 COPD patients (77.2% ex- or current smokers, 79.5% male) were consecutively enrolled. Results - Bronchiectasis was present in 54.5% of patients (score ≥2/12) and there was significant inter-observer correlation in the scoring (r=0.63, p<0.0001). Scores were highest in the lower lobes and lowest in the middle lobes (1.66 vs 0.86, p<0.000). Patients with widespread bronchiectasis (score ≥6/12) had a trend towards reduced bronchodilator reversibility (4% vs 9%, p=0.08) than those with limited bronchiectasis. Emphysema was present in 77.2% and ILD in 11.36%. The overall prevalence of emphysema was not different between patients with and without previous pulmonary tuberculosis (PTB) n=30 (13.63%), but in those with previous PTB, a higher number of subjects with middle (p=0.002) and lower (p=0.017) lobe emphysema, higher severity score (p=0.029), higher prevalence of panlobular emphysema (p=0.015), and more extensive centrilobular emphysema (p=0.036) were observed. Conclusions - In this study, we found a higher prevalence of bronchiectasis than previously reported which may reflect the heterogeneity of COPD patients in a general respiratory clinic. Radiological features of bronchial wall thickening and mild bronchiectasis were commonly seen and when widespread this may result in reduced bronchodilator reversibility; however, the presence of radiological bronchiectasis was not related to disease severity. COPD patients with previous PTB had unique features of bronchiectasis and emphysema on HRCT, which were associated with significant dyspnea and higher frequency of severe exacerbations.
URI: http://hdl.handle.net/20.500.12188/25609
Appears in Collections:Faculty of Medicine: Conference papers

Files in This Item:
File Description SizeFormat 
ABSTRACT_BOOK_draft_COPD2023v2.pdf1.26 MBAdobe PDFView/Open
Show full item record

Page view(s)

98
checked on Apr 26, 2024

Download(s)

19
checked on Apr 26, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.